 |
인쇄하기
취소
|
Boryung Pharmaceutical Co. made $200 million contract including licensing-out contract of 'Kanarb'
(Yakup Shinmoon)
On Jan 9, Boryung Pharmaceutical Co. made a licensing-out contract about new hypertension drug 'Kanarb' with Gloria in China, followed by 13 countries in Latin America including Mexico, Brazil, Russia.
Boryung Pharmaceutical Co. provides licence of new hypertension drug 'Kanarb (Fimasartan)' and provides 'Kanarb' in License Fee (Royalty) of $ 5.4 million.
According to...
On Jan 9, Boryung Pharmaceutical Co. made a licensing-out contract about new hypertension drug 'Kanarb' with Gloria in China, followed by 13 countries in Latin America including Mexico, Brazil, Russia.
Boryung Pharmaceutical Co. provides licence of new hypertension drug 'Kanarb (Fimasartan)' and provides 'Kanarb' in License Fee (Royalty) of $ 5.4 million.
According to...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.